Edwards Thomas A. 4
4 · ChemoCentryx, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Edwards Thomas A.
Director
Transactions
- Sale
Common Stock
2021-03-02$70.08/sh−600$42,048→ 119,857 total - Sale
Common Stock
2021-03-02$70.03/sh−500$35,015→ 120,457 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $70.03 to $70.13 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.